pRESSURE bIOSCIENCE

Pressure BioSciences (PBIO) Receives $1.5M Contract for UltraShear Nanoemulsified CBD.

CBD Supply MD, a Leading Maryland-Based CBD Retailer, to Introduce PBIO's UltraShear Processed, Best-in-Class Nanoemulsified CBD Products Across the Multi-State Mid-Atlantic Region SOUTH EASTON, MA...

Asia-Pacific: A Region of Stability Amidst Economic Uncertainty

Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in these turbulent...

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and Multiple NASH Biomarkers. Definitely NOT for traders or...

Topical PTSD Drug Poised for Human Trials.

In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid and psychedelic...

Report: Expedia, Doordash, eCommerce Fashion Retailer and YouTube All Rolled Into One?

Society Pass (SOPA) has Acquired and is Operating in Six Verticals, With More to Come. Society Pass currently has its fingers in the Travel, Fashion,...

Is Smart for Life (SMFL) $4.30, a Bargain Post Reverse Split?

We Think Yes..! With the year just finished ringing in $17.8 million in revenues, versus a market capitalization of just $3 million - we actually...

The Ketamine Endgame. Silo Pharmaceutical (SILO).

James Kuo, M.D. the Vice President of R&D for Silo Pharma (SILO) will speak at the 3rd Annual Psychedelic Therapeutics and Drug Development Conference. Dr....

Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.

If we average out the two most recent price targets this month, we come out with a potential gain of 337% and that ain't...

Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment...

Topline Results anticipated by the end of Q2 2023 CRANFORD, N.J. , April 3, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced...

Smart for Life (SMFL) Reports Revenue Increases 96.9% to $17.8 Million for 2022

Smart for Life Reports 2022 Financial Results and Provides Business Update (Bolding by IA Editor) BOCA RATON, Fla., March 31, 2023 (GLOBE NEWSWIRE) -- Smart for...

Latest article

Jeffrey Gundlach: Reckoning is Coming.

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...